| 11806348 | Methods of treatment using pharmaceutical capsule compositions comprising lumateperone mono-tosylate | Nov 7, 2023 |
| 11753419 | 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3'4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)phenyl)butan-1-one for treating conditions of the central nervous system and cardiac disorders | Sep 12, 2023 |
| 11690842 | Pharmaceutical capsule compositions comprising lumateperone mono-tosylate | Jul 4, 2023 |
| RE048839 | Methods and compositions for sleep disorders and other disorders | Dec 7, 2021 |
| RE048825 | 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-fluorophenyl)-1-butanone toluenesulfonic acid salt crystal forms | Nov 23, 2021 |
| 11052084 | Pharmaceutical capsule compositions comprising lumateperone mono-tosylate | Jul 6, 2021 |
| 11026951 | Methods of treating bipolar disorder | Jun 8, 2021 |
| 10960009 | Methods of treating schizophrenia and depression | Mar 30, 2021 |
| 10695345 | Pharmaceutical capsule compositions comprising lumateperone mono-tosylate | Jun 30, 2020 |
| 10464938 | Pharmaceutical compositions comprising ((6bR,10aS)-1-(4-fluorophenyl)-4-(3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)butan-1-one or pharmaceutically acceptable salts thereof | Nov 5, 2019 |
| 10117867 | Methods and compositions for sleep disorders and other disorders | Nov 6, 2018 |
| 09956227 | Method for the treatment of residual symptoms of schizophrenia | May 1, 2018 |
| 09616061 | Methods and compositions for sleep disorders and other disorders | Apr 11, 2017 |
| 09199995 | 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-fluorophenyl)-1-butanone toluenesulfonic acid addition salt and salt crystals | Dec 1, 2015 |
| 09168258 | Methods and compositions for sleep disorders and other disorders | Oct 27, 2015 |
| 08648077 | 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-fluorophenyl)-1-butanone toluenesulfonic acid addition salt and salt crystals | Feb 11, 2014 |
